ID27724A - Penstabil sediaan parmasi dari turunan-turunan asam gamma-aminobutira dan proses pembuatannya - Google Patents

Penstabil sediaan parmasi dari turunan-turunan asam gamma-aminobutira dan proses pembuatannya

Info

Publication number
ID27724A
ID27724A IDW20002352A ID20002352A ID27724A ID 27724 A ID27724 A ID 27724A ID W20002352 A IDW20002352 A ID W20002352A ID 20002352 A ID20002352 A ID 20002352A ID 27724 A ID27724 A ID 27724A
Authority
ID
Indonesia
Prior art keywords
parmation
aminobutira
provisions
gamma
stability
Prior art date
Application number
IDW20002352A
Other languages
English (en)
Inventor
Akira Aomatsu
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15097118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27724(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ID27724A publication Critical patent/ID27724A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerisation Methods In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20002352A 1998-05-15 1999-05-10 Penstabil sediaan parmasi dari turunan-turunan asam gamma-aminobutira dan proses pembuatannya ID27724A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13311398 1998-05-15

Publications (1)

Publication Number Publication Date
ID27724A true ID27724A (id) 2001-04-26

Family

ID=15097118

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002352A ID27724A (id) 1998-05-15 1999-05-10 Penstabil sediaan parmasi dari turunan-turunan asam gamma-aminobutira dan proses pembuatannya

Country Status (37)

Country Link
US (1) US7309719B1 (id)
EP (1) EP1077692B1 (id)
JP (1) JP4612923B2 (id)
KR (1) KR100602047B1 (id)
CN (1) CN1303991C (id)
AR (1) AR020323A1 (id)
AT (1) ATE271864T1 (id)
AU (1) AU768277B2 (id)
BR (1) BR9910508B1 (id)
CA (1) CA2327285C (id)
CO (1) CO5021224A1 (id)
CR (1) CR6026A (id)
CU (1) CU23253B7 (id)
DE (1) DE69918977T2 (id)
DK (1) DK1077692T3 (id)
EG (1) EG26803A (id)
ES (1) ES2221385T3 (id)
GT (1) GT199900069A (id)
HK (1) HK1036586A1 (id)
HN (1) HN1999000072A (id)
HU (1) HU228771B1 (id)
ID (1) ID27724A (id)
IL (2) IL139298A0 (id)
IS (1) IS2233B (id)
MY (1) MY157878A (id)
NO (1) NO328959B1 (id)
NZ (1) NZ508015A (id)
PA (1) PA8472801A1 (id)
PE (1) PE20000556A1 (id)
PL (1) PL204921B1 (id)
PT (1) PT1077692E (id)
SI (1) SI1077692T1 (id)
SV (1) SV1999000064A (id)
TW (1) TWI243054B (id)
UY (1) UY25512A1 (id)
WO (1) WO1999059573A1 (id)
ZA (1) ZA200006484B (id)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
EP1384473A1 (en) * 2000-06-16 2004-01-28 Teva Pharmaceutical Industries Ltd. Stable gabapentin containing more than 20 ppm of chlorine ion
NZ523546A (en) * 2000-06-16 2005-04-29 Teva Pharma Stable pharmaceutical compositions of gabapentin having PH within the range 6.8 to 7.3 comprising less than 0.5% by weight of a corresponding lactum
EP1430893A1 (en) * 2000-06-16 2004-06-23 Teva Pharmaceutical Industries Ltd. Stable gabapentin containing more than 20 ppm of chloride ion
ES2193008T3 (es) * 2000-06-16 2004-07-01 Teva Pharmaceutical Industries Ltd. Gabapentina estable que contiene mas de 20 ppm de iones de cloro.
US7056951B2 (en) 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
MXPA03009392A (es) 2001-05-25 2004-01-29 Warner Lambert Co Composicion famaceutica liquida.
SI1711169T1 (sl) * 2004-02-04 2007-10-31 Alembic Ltd Obložene minitablete venlafaksin hidroklorida s podaljšanim sproščanjem
WO2005115372A1 (en) * 2004-05-17 2005-12-08 Odessa Pharma, Llc Decreasing brain neuronal glutamate levels using alpha-keto branched chain amino acids
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
WO2007107835A2 (en) * 2006-03-17 2007-09-27 Aurobindo Pharma Limited Stable liquid formulations of antiepileptic agents
DE102007019071A1 (de) 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
JP2010043063A (ja) 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
RU2559083C9 (ru) * 2009-05-19 2016-01-20 Неуродерм Лтд Композиции для непрерывного введения ингибиторов допа-декарбоксилазы
HU230031B1 (hu) 2010-03-01 2015-05-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
EP2389934A1 (en) 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Tablet Formulations of Pregabalin
EP2389933A1 (en) 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Pregabalin Compositions
PT3326615T (pt) 2010-11-15 2020-03-23 Neuroderm Ltd Administração continua de l-dopa, inibidores de dopa descarboxilase, inibidores de catecol-o-metil transferase e composições para os mesmos
CA2875446A1 (en) 2012-06-05 2013-12-12 Neuroderm Ltd. Compositions comprising apomorphine and organic acids and uses thereof
CN103494796B (zh) * 2013-09-30 2016-01-20 浙江华义医药有限公司 普瑞巴林稳定的药物组合物及其制备方法
WO2015114509A1 (en) 2014-01-28 2015-08-06 Ranbaxy Laboratories Limited Stabilized gastroretentive tablets of pregabalin
BR112016021034A8 (pt) 2014-03-13 2021-06-29 Neuroderm Ltd composição farmacêutica, uso da mesma e kit
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
WO2015144825A1 (en) * 2014-03-27 2015-10-01 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin
EP2929878A1 (en) * 2014-04-09 2015-10-14 Arven Ilac Sanayi ve Ticaret A.S. Extended release formulations of gabapentin
CN107920987A (zh) 2015-05-26 2018-04-17 艾萨·欧蒂迪 控制延缓释放普瑞巴林
JP6919119B2 (ja) * 2017-01-23 2021-08-18 日新製薬株式会社 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
JPWO2020071546A1 (ja) 2018-10-04 2021-09-02 株式会社 メドレックス 非水系溶媒により安定化された製剤
US10792262B1 (en) 2019-07-29 2020-10-06 Saol International Limited Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
US11654124B2 (en) 2019-07-29 2023-05-23 Amneal Pharmaceuticals Llc Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
WO2021079887A1 (ja) 2019-10-25 2021-04-29 国立大学法人京都大学 タウオパチーの予防又は治療剤
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
CN112843015A (zh) * 2021-04-08 2021-05-28 海南鑫开源医药科技有限公司 一种加巴喷丁胶囊制剂及其制备方法
WO2023055457A1 (en) 2021-09-29 2023-04-06 Amneal Pharmaceuticals Llc Baclofen-containing granule formulations and reduced patient exposure to metabolite variations

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
US4255448A (en) * 1979-09-10 1981-03-10 Wisconsin Alumni Research Foundation Method for reducing epileptiform activity
GB8311804D0 (en) * 1983-04-29 1983-06-02 Merrell Toraude & Co Treatment of seizure disorders and pharmaceutical compositions
US4595697A (en) * 1984-03-28 1986-06-17 Merrell Dow Pharmaceuticals Inc. Treatment of seizure disorders and pharmaceutical compositions useful therein
CA1249968A (en) 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
JPS63253022A (ja) * 1987-04-08 1988-10-20 Nitto Electric Ind Co Ltd バクロフエン外用製剤
PH26730A (en) 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
DE3928183A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
US5025035A (en) 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
GB9023585D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
JPH0597703A (ja) * 1991-10-04 1993-04-20 Yamanouchi Pharmaceut Co Ltd 改変型組織プラスミノーゲン活性化因子含有組成物
SG48288A1 (en) * 1992-05-20 1998-04-17 Univ Northwestern Gaba and l-glutamic acid analogs for antiseizure treatment
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5792451A (en) * 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
JP3467794B2 (ja) * 1993-03-09 2003-11-17 日本油脂株式会社 学習能向上剤
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
JPH0867636A (ja) * 1994-08-30 1996-03-12 Yamanouchi Pharmaceut Co Ltd 播種性血管内凝固症候群（ｄｉｃ）の予防治療薬
GB9420784D0 (en) * 1994-10-14 1994-11-30 Glaxo Group Ltd Medicaments
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
US5510381A (en) 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
JPH1017476A (ja) * 1996-06-28 1998-01-20 Nippon Seiyaku Kk 敗血症用非経口製剤及びそれによる予防及び治療方法
EP0964691A4 (en) * 1996-07-22 2002-10-30 Cognetix Inc USE OF CONANTOKINE
IL126999A (en) * 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
US5780431A (en) * 1996-09-20 1998-07-14 Neurobiological Technologies, Inc. Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
US6028102A (en) * 1998-02-24 2000-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anticonvulsant drugs and pharmaceutical compositions thereof
IT1311984B1 (it) * 1999-03-26 2002-03-22 Bioindustria Lab Italiano Medi Procedimento per la preparzione di gabapentin.
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
US6979462B1 (en) * 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
MXPA03011565A (es) * 2001-06-11 2004-10-28 Xenoport Inc Profarmacos de analogos de gaba, composiciones y usos de las mismas.

Also Published As

Publication number Publication date
EG26803A (en) 2014-09-21
HK1036586A1 (en) 2002-01-11
HUP0102022A3 (en) 2002-11-28
UY25512A1 (es) 1999-07-19
PE20000556A1 (es) 2000-08-10
CU23253B7 (es) 2007-12-17
DE69918977D1 (de) 2004-09-02
SV1999000064A (es) 2000-03-31
CA2327285A1 (en) 1999-11-25
CA2327285C (en) 2005-06-14
IS5666A (is) 2000-10-16
EP1077692A1 (en) 2001-02-28
NO328959B1 (no) 2010-06-28
KR100602047B1 (ko) 2006-07-19
MY157878A (en) 2016-07-29
WO1999059573A9 (en) 2000-05-04
CO5021224A1 (es) 2001-03-27
KR20010043611A (ko) 2001-05-25
AU768277B2 (en) 2003-12-04
DE69918977T2 (de) 2005-07-28
HU228771B1 (en) 2013-05-28
HUP0102022A2 (hu) 2001-11-28
US7309719B1 (en) 2007-12-18
JP2000034226A (ja) 2000-02-02
TWI243054B (en) 2005-11-11
IS2233B (is) 2007-04-15
CN1303991C (zh) 2007-03-14
IL139298A0 (en) 2001-11-25
EP1077692B1 (en) 2004-07-28
ATE271864T1 (de) 2004-08-15
HN1999000072A (es) 2000-06-05
CR6026A (es) 2008-08-26
AR020323A1 (es) 2002-05-08
BR9910508A (pt) 2001-01-02
NO20005768D0 (no) 2000-11-14
DK1077692T3 (da) 2004-12-06
AU4073599A (en) 1999-12-06
IL139298A (en) 2009-07-20
BR9910508B1 (pt) 2012-01-24
GT199900069A (es) 2000-11-04
PT1077692E (pt) 2004-12-31
WO1999059573A1 (en) 1999-11-25
SI1077692T1 (en) 2004-10-31
PL204921B1 (pl) 2010-02-26
CN1301155A (zh) 2001-06-27
NZ508015A (en) 2003-11-28
PA8472801A1 (es) 2001-12-14
ZA200006484B (en) 2002-02-11
PL344218A1 (en) 2001-10-08
JP4612923B2 (ja) 2011-01-12
NO20005768L (no) 2000-11-14
ES2221385T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
ID27724A (id) Penstabil sediaan parmasi dari turunan-turunan asam gamma-aminobutira dan proses pembuatannya
ID29380A (id) Penhilangan konstituen gas asam dari gas
ID21201A (id) Metode dan peralatan untuk pembuatan asam terephtalat murni
ID23502A (id) Pembuatan asam tereftalat
ID21753A (id) Proses pembuatan asam asetat
ID27167A (id) Komposisi-komposisi kolektor mineral dari asam hidroksamik berlemak dalam campurannya dengan suatu minyak dan proses pembuatannya
ID18000A (id) Proses pembuatan asam asetat selektif
ID24730A (id) Senyawa-senyawa heterosiklik untuk penghambatan sekresi asam lambung, proses pembuatan dan komposisi-komposisi farmasinya
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID28146A (id) Benzoilsikloheksanadion, proses pembuatan dan penggunaannya sebagai herbisida dan zat pengatur tumbuh
ID15886A (id) Pembuatan alkil ester secara kontiniu dari asam met-akrilik
ID26395A (id) Turunan asam gamma-aminobutirat yang mengandung komposisi padat dan proses pembuatannya
ID25950A (id) Katalis-katalis untuk memproduksi aldehid tidak jenuh dan asam karboksilat tidak jenuh dan proses untuk produksi aldehid tidak jenuh dan asam karboksilat tidak jenuh menggunakan katalis
ID23963A (id) Proses pembuatan vinil asetat
ID26102A (id) Proses pembuatan senyawa-senyawa stilbena
ID29030A (id) Proses pembuatan asam amino bersifat asam dari n-asil rantai panjang
ID15885A (id) Pembuatan alkil ester secara kontiniu dari asam met-akrilik
ID26690A (id) Komposisi katalis, metoda pembuatannya dan metoda pemurnian asam tereftalat
ID24863A (id) Proses pembuatan vinil ester dari butenoligomeran
ID28612A (id) Metode pembuatan asam tereftalat dan asam isoftalat murni dari campuran xilena
ID28447A (id) Proses polimerisasi kontinu pembuatan poliamida-poliamida dari omega-aminonitril
ID28639A (id) Mentaga kacang rendah kalori dan proses pembuatannya
ID28021A (id) Proses pemisahan dan pemurnian asam adipat
ID25547A (id) Proses pembuatan asam l-askorbat
DE69822711D1 (de) Verfarhen zur Herstellung von Dialkylnaphthalinen